172 related articles for article (PubMed ID: 24293286)
1. Biparietal diameter at 11 to 13 weeks' gestation in fetuses with holoprosencephaly.
Khalil A; Papageorghiou A; Bhide A; Akolekar R; Thilaganathan B
Prenat Diagn; 2014 Feb; 34(2):134-8. PubMed ID: 24293286
[TBL] [Abstract][Full Text] [Related]
2. Biparietal diameter at 11-13 weeks' gestation in fetuses with open spina bifida.
Khalil A; Coates A; Papageorghiou A; Bhide A; Thilaganathan B
Ultrasound Obstet Gynecol; 2013 Oct; 42(4):409-15. PubMed ID: 23362051
[TBL] [Abstract][Full Text] [Related]
3. Biparietal diameter-to-crown-rump length disproportion in first-trimester fetuses with holoprosencephaly.
Sepulveda W; Wong AE; Andreeva E; Odegova N; Martinez-Ten P; Meagher S
J Ultrasound Med; 2014 Jul; 33(7):1165-9. PubMed ID: 24958402
[TBL] [Abstract][Full Text] [Related]
4. Lateral ventricles in fetuses with aneuploidies at 11-13 weeks' gestation.
Loureiro T; Ushakov F; Maiz N; Montenegro N; Nicolaides KH
Ultrasound Obstet Gynecol; 2012 Sep; 40(3):282-7. PubMed ID: 22605664
[TBL] [Abstract][Full Text] [Related]
5. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
[TBL] [Abstract][Full Text] [Related]
6. The frontal space measurement in euploid and aneuploid pregnancies at 11-13 weeks' gestation.
Yazdi B; Riefler P; Fischmüller K; Sonek J; Hoopmann M; Kagan KO
Prenat Diagn; 2013 Dec; 33(12):1124-30. PubMed ID: 23893400
[TBL] [Abstract][Full Text] [Related]
7. Dilated fourth ventricle in fetuses with trisomy 18, trisomy 13 and triploidy at 11-13 weeks' gestation.
Loureiro T; Ferreira AF; Ushakov F; Montenegro N; Nicolaides KH
Fetal Diagn Ther; 2012; 32(3):186-9. PubMed ID: 22846426
[TBL] [Abstract][Full Text] [Related]
8. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH
Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
[TBL] [Abstract][Full Text] [Related]
9. Crown-rump length in chromosomally abnormal fetuses at 10 to 13 weeks' gestation.
Kuhn P; Brizot ML; Pandya PP; Snijders RJ; Nicolaides KH
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):32-5. PubMed ID: 7847557
[TBL] [Abstract][Full Text] [Related]
10. The cavum septi pellucidi in euploid and aneuploid fetuses.
Abele H; Babiy-Pachomow O; Sonek J; Hoopmann M; Schaelike M; Kagan KO
Ultrasound Obstet Gynecol; 2013 Aug; 42(2):156-60. PubMed ID: 23303556
[TBL] [Abstract][Full Text] [Related]
11. First Trimester Screening for Fetal Aneuploidies Using Placental Growth Factor: The Great Obstetrical Syndrome (GOS) Study.
Boutin A; Demers S; Gasse C; Giguère Y; Tétu A; Laforest G; Bujold E
J Obstet Gynaecol Can; 2018 Aug; 40(8):1044-1049. PubMed ID: 30103877
[TBL] [Abstract][Full Text] [Related]
12. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
Snijders RJ; Sebire NJ; Nayar R; Souka A; Nicolaides KH
Am J Med Genet; 1999 Sep; 86(3):205-7. PubMed ID: 10482866
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials.
Perni SC; Predanic M; Kalish RB; Chervenak FA; Chasen ST
Am J Obstet Gynecol; 2006 Jan; 194(1):127-30. PubMed ID: 16389021
[TBL] [Abstract][Full Text] [Related]
14. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
[TBL] [Abstract][Full Text] [Related]
15. Sphenofrontal distance in euploid and aneuploid fetuses.
Abele H; Sonek J; Goldschmid D; Wagner P; Hoopmann M; Kagan KO
Ultrasound Obstet Gynecol; 2017 Aug; 50(2):187-191. PubMed ID: 27550089
[TBL] [Abstract][Full Text] [Related]
16. The BS/BSOB Ratio in Aneuploidy Fetuses at 11-13 Weeks Gestation.
Hsiao CH; Cheng PJ; Shaw SW; Tseng YJ; Chen RC; Chu WC
Fetal Diagn Ther; 2015; 37(4):321-6. PubMed ID: 25721690
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
18. Is nuchal translucency a useful aneuploidy marker in fetuses with crown-rump length of 28-44 mm?
Grande M; Solernou R; Ferrer L; Borobio V; Jimenez JM; Bennasar M; Soler A; Borrell A
Ultrasound Obstet Gynecol; 2014 May; 43(5):520-4. PubMed ID: 24006271
[TBL] [Abstract][Full Text] [Related]
19. Is Cisterna Magna Width a Useful First-Trimester Marker of Aneuploidy?
Pauta M; Grande M; Borobio V; Illanes C; Soler A; Nogué L; Borrell A
Fetal Diagn Ther; 2020; 47(6):457-463. PubMed ID: 31694020
[TBL] [Abstract][Full Text] [Related]
20. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
